pridinol
Small moleculeexperimental
Pridinol, sold under the brand name Myopridin, is a muscle relaxant that is used as an antiparkinsonian and anticholinergic drug. It has also been evaluated for the treatment of muscle related pain. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 30, 2020 (NCT04275492)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Loading structure…
SMILES
OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1- Mol. weight
- 295.43 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL404215 ↗
- WikipediaPridinol ↗
- ChEMBLCHEMBL1528011 ↗
Also known as
- pridinol
- pridinol
- pridinol
- pridinol
- pridinol
- pridinol methanesulfonate
- pridinol methanesulfonate salt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04275492 | N/A | Apr 30, 2020 | Zhejiang University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2020 |
1 organizations
Page 1 / 1